Australia's Mesoblast gains as quarterly loss narrows
** Shares of Mesoblast Ltd MSB.AX jump as much as 6.7% to
A$1.11, their biggest intraday pct gain since May 3
** The biotech co posts loss after tax of $18.6 mln for the
quarter ended March 31, compared with loss of $21.3 mln posted a
year earlier
** MSB says total revenue fell to $1.9 mln from $2 mln
** Stock up 19.5% YTD, as of last close
(Reporting by Harish Sridharan in Bengaluru)
((harish.sridharan@thomsonreuters.com))
Recent news on Mesoblast
See all newsBrief: Mesoblast Reports QTRLY Ryoncil Net Revenues Of $30.3 Million
ASX-shares of Mesoblast rise after back-treatment drug hits patent target
Australia's Mesoblast soars on bagging licence for Mayo Clinic-developed tech
Brief: Mesoblast Acquires CAR Platform For Precision-Enhanced Cell Products
Brief: Mesoblast Says Ryoncil's Net Revenue For Quarter Increases To US$30.3M